MAXgene® GMP Transfection Reagent, Powder (26435)


MAXgene® GMP is a high-performance, cGMP-grade transfection reagent engineered specifically for efficient plasmid DNA delivery in large-scale production.

SKU Size: 26435-1 (1g)
Contact Us for Pricing
MAXgene® GMP is a high-performance, cGMP-grade transfection reagent engineered specifically for efficient plasmid DNA delivery in large-scale production. It is designed to support the manufacture of high-titer adeno-associated viral (AAV) and lentiviral (LV) vectors, as well as recombinant protein and monoclonal antibody (mAb) production. Trusted by researchers worldwide, MAXgene® is used in many clinical trials and approved therapies, making it a leading choice for translational research and therapeutic development.

As part of the Kyfora PEI MAX® line, MAXgene® GMP combines the proven performance of our research-grade products with the scalability, validation, and regulatory compliance needed for a smooth transition from development to clinical trials up through commercialization. MAXgene GMP is fully synthetic and manufactured under cGMP 21 CFR 820 (ISO 13485) Quality Management System.
Store At Temperature 2 - 8°C
Shipping Condition Cold pack

Broad-Spectrum Transfection

  • Efficiently transfects a wide array of cell types, making it ideal for diverse applications in bioproduction.

High Transfection Efficiency

  • Optimized to deliver superior transfection rates with low cytotoxicity, maximizing viral vector, protein, and mAb titers.

1 in 5 Clinical Trials

  • Validated in 50+ cell and gene therapy clinical trials, affirming its reliability and effectiveness in therapeutic development.

Lot-to-Lot Consistency

  • Provides dependable, reproducible results across batches for consistent performance in clinical and commercial applications.

User-Friendly

  • Easily integrates into diverse workflows, adaptable from research to production environments.

Scalable

  • Suitable for use in well plates, flasks, and bioreactors, ensuring seamless scale-up from bench to large-scale biomanufacturing.

Cost Effective

  • Optimized for economic efficiency, offering substantial value compared to alternative transfection solutions.

Clinical and Commercial Ready

  • Specifically developed for viral vector production, recombinant protein, and mAb manufacturing at all stages of development.

Seamless Transition

  • Complements research-grade products for streamlined process development and scale-up.
MAXgene® GMP is a high-performance, cGMP-grade transfection reagent engineered specifically for efficient plasmid DNA delivery in large-scale production. It is designed to support the manufacture of high-titer adeno-associated viral (AAV) and lentiviral (LV) vectors, as well as recombinant protein and monoclonal antibody (mAb) production. Trusted by researchers worldwide, MAXgene® is used in many clinical trials and approved therapies, making it a leading choice for translational research and therapeutic development.

As part of the Kyfora PEI MAX® line, MAXgene® GMP combines the proven performance of our research-grade products with the scalability, validation, and regulatory compliance needed for a smooth transition from development to clinical trials up through commercialization. MAXgene GMP is fully synthetic and manufactured under cGMP 21 CFR 820 (ISO 13485) Quality Management System.
Store At Temperature 2 - 8°C
Shipping Condition Cold pack

Broad-Spectrum Transfection

  • Efficiently transfects a wide array of cell types, making it ideal for diverse applications in bioproduction.

High Transfection Efficiency

  • Optimized to deliver superior transfection rates with low cytotoxicity, maximizing viral vector, protein, and mAb titers.

1 in 5 Clinical Trials

  • Validated in 50+ cell and gene therapy clinical trials, affirming its reliability and effectiveness in therapeutic development.

Lot-to-Lot Consistency

  • Provides dependable, reproducible results across batches for consistent performance in clinical and commercial applications.

User-Friendly

  • Easily integrates into diverse workflows, adaptable from research to production environments.

Scalable

  • Suitable for use in well plates, flasks, and bioreactors, ensuring seamless scale-up from bench to large-scale biomanufacturing.

Cost Effective

  • Optimized for economic efficiency, offering substantial value compared to alternative transfection solutions.

Clinical and Commercial Ready

  • Specifically developed for viral vector production, recombinant protein, and mAb manufacturing at all stages of development.

Seamless Transition

  • Complements research-grade products for streamlined process development and scale-up.

Any questions?

If we still haven't answered your question, you can contact us below and we will get back to you as soon as possible.
Customer support

For technical inquiries contact techsupport@kyfora.com,

For pricing and general questions contact info@kyfora.com

You may also like

Recently viewed